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The present study was aimed at evaluating whether single intermittent acute cervical vagus nerve stimulation (ACVS), pro-
vided at a frequency which exhibits a clinical efficacy, may influence brain neurotrophins and hippocampal plasticity. 
With this purpose, the brain of adult male rats undergoing ACVS was used to analyze the expression of Nerve Growth Fac-
tor (NGF) and Brain-Derived Neurotrophic Factor (BDNF) in brain areas known to synthetize these growth factors, and the 
expression the neural cell adhesion molecule (NCAM), the synaptophysin (SYP) and biosynthetic GABA (GAD67) in the hip-
pocampus.
The effects of ACVS on NGF and BDNF protein and mRNA in hippocampus, hypothalamus and cortex two hours after stimula-
tion were shown to be dependent on the frequencies of ACVS stimulation. Prolonged (three days post stimulation) modifications 
of NGF and BDNF were also observed in the hippocampus of ACVS rats. An early enhancement of the plasticity markers NCAM, 
SYP and GAD67 was also found in ACVS hippocampus. Three days after stimulation, NCAM and GAD67 levels were still higher 
than controls. Immunohistochemistry confirms the stimulatory effects of ACVS on GABA showing an increase in GAD67-positive 
cells in the dentate gyrus and CA3 hippocampal areas. This study shows that ACVS affects brain NGF and BDNF synthesis in 
a frequency-dependent manner. Neurotrophins changes are associated with increased hippocampal plasticity, as demonstrated 
by the observed molecular and morphological modifications. These findings support the role of brain neurotrophins in the ACVS 
mechanism of action. Biomed Rev 2019;30:99-109
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INTRODUCTION 
The electrical stimulation of the cervical portion of the left 
vagal nerve (CVS) is an approved treatment for epilepsy and 
depression (1), and it is currently investigated in animals and 
humans	because	of	its	anti-inflammatory	and	anti-nociceptive	
action. In addition, the evidence that vagus  nerve stimulation 
(VNS) leads in enhanced memory in both animals (2,3) and 
humans (4,5), lead to the idea that CVS might be also an ef-
fective treatment for neurodegenerative diseases associated 
with cognitive decline. In spite of a large number of clinical 
investigations, the research into CVS’s mechanism of action 
is fragmentary and relatively recent. 
Electrophysiological studies in animals have indicated that 
CVS affects brain functions by a direct action on the nucleus 
of the solitary tract, which in turn sends projections to several 
areas including the cerebral cortex, the hippocampus, and the 
hypothalamus  (6-7). 
Emission	tomography	and	magnetic	resonance	confirmed	
that, together with brainstem, forebrain structures, such as the 
hippocampus are activated in humans (8) and rats (9) by VNS. 
Studies reporting the effect on memory retention (2, 4) 
and the enhancement of the long-term potentiation (10, 11) 
after acute stimulation, further indicate the involvement of 
hippocampus and suggest that VNS may trigger factors, and/
or events which regulate the neural activity and the activity-
dependent hippocampal plasticity. 
The neurotrophins, Nerve Growth Factor (NGF) and Brain 
Derived Neurotrophic Factor (BDNF) are largely known as 
potent regulators of brain neuronal activity. Changes of their 
synthesis or release are demonstrated to occur because of 
physiological	and	pathological	challenges,	including	inflam-
mation (12, 13). Stress, mood and neurodegeneration are also 
associated with alterations of neurotrophins levels in the brain 
(14).	The	anti-depressant	efficacy	of	anti-neurodegenerative	
treatments is strictly associated and/or dependent on the rebal-
ance or enhancement of brain neurotrophins-producing areas 
such as hippocampus, hypothalamus, and cortex (14, 15).
To the present day, only a few data are available on the 
effects of VNS on brain neurotrophins. By using implantable 
stimulatory devices, which stimulate continuously the vagus 
nerve, it was found that BDNF and NGF mRNAs in hippocam-
pus and cortex were increased and decreased respectively (17). 
Biggio and colleagues (18) using the same stimulatory param-
eters reported different effects of acute (3 hours) or chronic 
(1 month) VNS on BDNF levels and hippocampal plasticity.
Several human and animal studies demonstrated that the 
anti-inflammatory,	anti-depressant	or	anti-epileptic	effects	as	
well as the activation of subcortical brain areas, including the 
hippocampus and hypothalamus, and the cortex, produced 
by vagal nerve, are dependent on stimulation frequency (19). 
Beside this, the present study addresses the questions whether 
acute cervical vagus nerve stimulation (ACVS) at a frequency 
exhibiting	clinical	efficacy	 in	 rats	 (2,	17-19),	might	affects	
neurotrophins	 expression	 in	 the	 brain,	 and	 influence	 hip-
pocampal synaptic plasticity and memory, such as the neural 
cell adhesion molecule (NCAM) and the synaptophysin (SYP). 
In addition, since GABAergic neurons excitation promotes 
activity-dependent neurotrophins synthesis or release in the 
hippocampus	(20,	21),	and	contributes	to	the	clinical	efficacy	
of CVS as anti-epileptic treatment (17, 23), the effects on the 
distribution and expression of GAD67 were also analyzed.
MATERIALS AND METHODS
Animals, surgical procedures and electrical 
stimulation
Adult male Sprague-Dawley rats (260-320 g b. w.) were used 
in this study. The rats undergoing ACVS were deprived of food 
for 14-20 hours before surgery and were anaesthetized with 
injections of a mixture of ketamine (70 mg/kg) and xylazine 
(10 mg/kg) to keep the surgical level of anesthesia during 
stimulation. Body temperature was maintained at +37.2 ± 0.1 
˚C	(ATB-1100,	Nihon	Kohden,	Japan).	During	surgery,	oxygen	
level was continuously monitored by using pulse oxymeter 
(model 9847 V, Nonin Medical, Minneapolis, USA). 
To perform vagal stimulation, the left cervical segment of 
vagus	nerve	was	identified,	separated	from	the	surrounding	
tissues and placed on a pair of platinum wire electrodes im-
mersed	in	paraffin	oil	(Kebo	Lab.),	and	the	distal	end	of	the	
nerve was crushed (Fig.1A). This procedure was selected to 
decrease the potential interferences due to signals originated 
from muscles or tissues surrounding the stimulation area, or 
by the discharge of vagal efferents. 
The nerve was stimulated using a Wavetek function gener-
ator (Wavetek, San Diego, CA, USA) providing square-wave 
monophasic pulses (5 or 20 Hz; 2,5 ms; 2,5 V). The nerve 
was stimulated for 4 periods of 30 s with a 5-min interval 
(ACVS). The control group (Sham) was prepared identically, 
the nerve put on the electrode but no electrical stimulation 
provided. The other groups included non-stimulated but fast-
ed rats (Fasted) and naïve rats (CTR).
All animal experiments were carried out in accordance 
with	the	U.K.	Animals	(Scientific	Procedures)	Act,	1986	and	
associated guidelines, the European Communities Council 
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Figure 1. Levels of NGF protein (A, C, E) and mRNA (B, D, F) in the brain areas of hippocampus, cortex and hypothalamus 
of rats at 120 min after ACVS. Results are reported as average respect to Control (=100%). Statistical significance <0.05 vs 
a=Control, b=Fasted and c=Sham.  
Directive of 24 November 1986 (86/609/EEC) or the National 
Institutes of Health guide for the care and use of Laboratory 
animals (NIH Publications No. 8023, revised 1978), and 
the intramural ethical committees. All efforts were made to 
minimize the number of animals used and the occurrence of 
suffering and injuries.
Experimental design and tissue sample collections
The experimental design includes a short term and a long-
term study, which are referred to as Experiment 1 and Ex-
periment 2, respectively. 
In Experiment 1, four rats from each treatment group were 
sacrificed	(within	120	min	from	the	stimulation)	by	decapita-
tion. Brains were harvested and hippocampus, hypothalamus 
and cortex were collected for neurotrophins measurement. 
Extracts from the hippocampus were further used to analyze 
the expression of plasticity markers by western blot.
In the Experiment 2, ACVS (20 Hz; 2,5 ms; 2,5 V) and 
Sham rats were moved to their cages and main tained on a 
12 h light–dark cycle and provided food and water ad libi-
tum	for	three	days	before	sacrifice.	This	second	experiment	
explores the late effects of ACVS on hippocampus, by ana-
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lyzing the expression levels of neurotrophins and plasticity 
markers. The immunohistochemical distribution of GAD67 
in hippocampus was also analyzed. To perform the immuno-
histological studies, Sham and ACVS rats were intracardia-
cally perfused with 4% Paraformaldehyde, the brains were 
removed	and	post-fixed	 for	24	h.	After	one	day	 in	 sucrose	
phosphate buffer solution, the brains were cut as described 
follow.
Tissue analysis
Proteins were extracted by tissue ultrasonication in Tris-buffer 
pH 7.00 (Tris-acetate 20 mM pH 7.5, Nacl 150 mM, EDTA 1 
mM, EGTA 1 mM, sodium-pyrophosphate 2.5 mM, Ortovana-
date	1	mM,	β-Glycerolphosphate	1	mM,	NaF	100	mM,	PMSF	1	
mM, leupeptin 1 µg/ml) and then centrifuged at 10.000 g. Total 
protein content was determined in the supernatants by using 
micro-lowry assay. Protein extracted from the hippocampus, 
hypothalamus and cortex were used to analyze the effects of 
ACVS on the expression levels of NGF and BDNF. Extracts 
from hippocampus were used for western blot analysis. 
NGF and BDNF analysis
Protein extracted form hypothalamus, cortex and hippocam-
pus were used for measuring the NGF and BDNF levels by 
ELISA assay using the rat b-NGF Duoset Elisa (R&D Systems, 
Inc., Minneapolis, MN, USA), following the manufacturer’s 
instructions.	The	assay	is	specific	for	rat	b-NGF	with	approxi-
mately 0.1% and 50% cross-reactivity with human and mouse 
recombinant b-NGF respectively, and has no cross-reactivity 
with other human or rat growth factors. The colorimetric 
reaction product was measured at 450 nm using a microplate 
reader (Dynatech MR 5000; PBI International, Dynatech 
International, Edgewood, NY, USA). Results are expressed 
as pg/mg protein (mean ± SD).
The total RNA was extracted from the half hippocampal, 
cortex and hypothalamus tissues by using the TRIzol Kit 
(Gibco) and complementary DNA (cDNA) was synthesized 
from 2 mg of total RNA using 200 Units of M-MLV reverse 
transcriptase (Promega Italia, Milano, Italy) in 20 ml of total 
volume reaction containing: 250 ng Oligo (dT)12–18 primer, 
0.5 Units RNasin ribonuclease inhibitor and 0.5 mM dNTP in 
5µl reaction buffer (250 mM Tris–Cl pH 8.3, 375 mM KCl, 
15 mM MgCl2, 50 mM DTT). The mixture was incubated at 
42 °C for 1 h and the reaction was terminated with an addi-
tional incubation at 95 °C for 5 min. The cDNAs were used to 
evaluate the NGF (primers TCCACCCACCCAGTCTTCCA/
GCCTTCCTGCTGAGCACACA) and BDNF (primers 
AGCTGAGCGTGTGTGACAGT/TCCATAGTAAGGGCC-
CGAAC) mRNA expression levels by RT-PCR using GAPDH 
as housekeeping gene. 
Western blot analysis 
Equal protein amounts were loaded on a 10% SDS-PAGE 
gel and electrophoretically transferred to nitrocellulose mem-
branes later blocked in low-fat milk (10% in Tris buffer and 
0.1% Tween-20) and washed three times for 10 min each at 
RT in TBS-T. Samples were exposed to the following primary 
antibodies rabbit polyclonal GAD67, mouse monoclonal anti-
synaptophysin (SYP), rabbit polyclonal anti-NCAM (1:1000, 
Merk-Millipore; Italy). The blots were washed and incubated 
for 1 h with anti-rabbit or anti-mouse horseradish peroxidase 
conjugated antibody (Amersham Pharmacia Biotech Italia). 
These steps were followed by incubation for 1 h with second-
ary antibodies. Immunoblot analyses were performed using a 
chemiluminescence detection kit (ECL) as the chromophore 
(ECL system by Amersham Bioscience) and exposed to Hy-
perfilm.	
The integrate density (ID) of the bands was recorded and 
quantified	by	the	public	domain	image	NIH	Image	processing	
and analysis program for the Macintosh. The β-actin band im-
munoreactivity was used to normalize for sample-to-sample 
variability. 
GAD67 immunohistochemistry
Sham and ACVS rats were intracardiacally perfused with 4% 
Paraformaldehyde,	the	brains	were	removed	and	post-fixed	for	
24 h. After one day in sucrose phosphate buffer solution, the 
brains	were	cut	as	described	follow.	Free	floating	single	or	dou-
ble	immunostaining	was	performed	on	fifteen-micron	cryostat	
sections using monoclonal anti-GAD67 (1:2500, Merk-Milli-
pore; Italy) as primary antibody. The sections were incubated 
overnight and further processed for immunoperoxidase with 
the ABC Vectastain Kit (Vector Lab. Inc. Burlingame, USA) 
following the manufacturer’s instructions, using DAB or GS as 
chromogen.	Staining	specificity	was	assessed	by	omission	of	
the primary antibody and by IgG isotype. Sections were then 
washed, mounted on a glass slides, coverslipped and visualized 
on the Nikon Eclipse E600 equipped with the Nikon DMX 
1200 digital camera connected to a PC computer. 
Statistical analysis 
Data were obtained by means of analysis of variance 
(ANOVA). The different controls and CVS conditions were 
considered as variables. Differences between groups were 
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Figure 2. Early effects of ACVS on the levels of BDNF protein (A, C, E) and mRNA (B, D, F) in the brain synthesizing areas. 
Results are reported as average respect to Control (=100%). Statistical significance <0.05 vs a=Control, b=Fasted, c=Sham.  
determined by Tukey’s post-hoc test: a p<0.05 was considered 
statistically	significant.	
RESULTS 
Effect of ACVS on brain NGF and BDNF 
The results of short term effects of ACVS using the low (5 Hz) 
and high (20 Hz) frequencies of stimulation (Experiment 1) 
show that starvation and ACVS frequencies differentially af-
fect the NGF and BDNF expression levels in the hippocampus, 
hypothalamus and cortex (Fig. 1 and 2 respectively). More than 
16 hours of starvation resulted in decreased NGF and BDNF 
protein levels in hippocampus and hypothalamus, while no 
significant	effects	were	noted	 in	 the	cortex.	No	differences	
in brain neurotrophins between Fasted and Sham rats were 
observed indicating that the surgical procedure per se did not 
affect NGF and BDNF levels. 
As far as the effect of frequency is concerned, we found 
that following simulation at 5 Hz, increase of NGF protein was 
observed in all three brain areas examined, while stimulation 
with 20 Hz resulted increase and decrease NGF in cortex and 
hypothalamus (Fig. 1). The NGF mRNA levels were increased 
in hippocampus, cortex and hypothalamus by ACVS at both 
frequencies. 
The levels of protein and mRNA of BDNF in hypothalamus 
and cortex was augmented by stimulation with 20 Hz, while 
no changes were found in the hippocampus (Fig. 2).
Three	 days	 after	 stimulation	with	 20	Hz,	 no	 significant	
variation of NGF and BDNF proteins in the hippocampus 
HIPPOCAMPUS
104
Biomed Rev 30, 2019
Rosso et al
Figure 3. Neurotrophins levels in hippocampus of ACVS rats 
at three days after stimulation. The values of NGF (A) and 
BDNF (B) are expressed as pg/mg protein, and the data are 
presented as mean ± s.d. Statistical significance <0.05 vs 
a=Control, b=Sham.  
of	Sham	rats	were	measured.	Following	ACVS,	a	significant	
increase	of	hippocampal	NGF	was	found,	while	no	significant	
changes of BDNF were observed (Fig. 3). 
Effects of AVCS on the expression of marker of 
plasticity in the hippocampus 
The results of the western blot analysis of NCAM, GAD67 
and SYP expression in hippocampus of adult rats are shown in 
Figure 4A-E. Two bands corresponding to the NCAM isoforms 
of 180 and 140 kDa were found in the hippocampal extracts 
while no smaller products, including the NCAM isoform at 
120 kDa, were visible in our experimental condition (Fig. 4A). 
The	band	densitometric	analysis	shows	a	significant	increase	of	
NCAM 180 kDa but no changes of NCAM 140 kDa in the hip-
pocampus of ACVS when compared to all the control groups 
(Fig.	 4B).	Consequently,	 a	 significant	 increase	 of	 180/140	
kDa ratio was also found in ACVS hippocampus with respect 
to controls. No variations were found comparing the NCAM 
expression levels of Control, Fasted and Sham rats (Fig. 4C).
GAD67 and SYP levels were also enhanced in ACVS rats 
reaching about four and two times the levels detected in 
Control and Fasted/Sham rats respectively (Fig. 4D and 4E). 
Although the mean GAD67 and SYP levels in the hippocam-
pus of Fasted and Sham rats were higher than in controls, this 
variation	did	not	reach	significant	levels.	
An enhancement of both the 180 and 140 kDa NCAM pro-
tein isoforms was also found in the hippocampus of ACVS rats 
three days after stimulation. Similar levels of the 180 and 140 
kDa NCAM were measured in Fasted rats (ratio=0,93±0,1), 
while	 a	 light	 increase	 (no	 significant)	was	 observable	 in	
Sham hippocampus (Fig. 5B). An up-regulation of the 180 
kDa NCAM with respect to the 140 kDa NCAM was found 
in	ACVS	rats	(Fig.	5A	and	B).	No	significant	changes	were	
observed in the expression levels of SYP in the hippocampus 
of Sham and ACVS rats with respect to Controls (Fig. 5C). 
GAD67 expression and distribution in hippocampus 
of ACVS rats
The Experiment 2 demonstrates that the stimulatory effect of 
ACVS on GAD67 is still evident three days after stimulation. 
Indeed, the microscopic observation shows an enhancement of 
GAD67 cell distribution in CA3 hippocampal areas (Fig. 6A 
and B) and in the dentate gyrus (Fig. 6C and D) of rats receiv-
ing vagal stimulation compared to Sham. Increased GAD67 
immunoreactivity was also found in other brain regions follow-
ing ACVS, including the cortex and hypothalamus. GAD67-
positive cells were also localized in the subventricular areas 
of both lateral and third ventricles (data not showed).
The	 results	 of	western	 blot	 analysis	 confirm	 the	 immu-
nohistochemical data showing an increase of GAD67 in the 
hippocampus	3d-ACVS,	while	no	significant	changes	were	
observed by comparing Sham with control Fasted group 
(Fig. 6E). 
DISCUSSION
The present study shows that electrical stimulation of the vagus 
nerve induces neurotrophin expression in brain target regions, 
and affects hippocampal plasticity. 
In line with Follesa  et al.,  (17) we found that vagus nerve 
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Figure 4. A-E The results of densitometric analyses of NCAM, GAD67 and SYP are reported in graphs B, D, E respectively. 
Graph C showed the ratio of the 180 and 140 kDa NCAM isoforms. Typical gels showing the effects of ACVS are presented 
in panel A. The values in the graphs are expressed as mean ± s.d. and the statistical significance is reported in parenthesis: 
a=Control, b=Fasted and c=Sham.  
stimulation modulates brain neurotrophin synthesis. However, 
at variance with these authors, who stimulated the vagus nerve 
by a Cybersonic device activated for 3 h at 30 Hz in continu-
ous cycle, in our study the electrical stimulation was done on 
an isolated nerve in anethetized rats avoiding vagal efferent 
activations and by applying low and medium frequencies and 
voltage. In this stimulatory condition, we found that ACVS 
with 5 Hz causes NGF increase in the hippocampus and hypo-
thalamus,	while	20	Hz	were	necessary	to	produce	significant	
changes in brain BDNF.
Humans and animal studies demonstrated that vagus nerve 
stimulatory parameters and conditions, including frequencies 
and voltage, duration of treatment, and awaking or sleeping 
status	of	the	subject	might	influence	the	brain	response.	For	
example, in depressed and epileptic patients, subcortical re-
gions, including the hypothalamus and hippocampus, respond 
to low levels of stimulation (pulse width 130 µs at 1 Hz – 30 sec 
on / 180 min off), while high levels of stimulation (pulse width 
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Figure 6. A-E The pictures show 
the distribution of GAD67 im-
munoreactivity in the CA3 area 
(A and B) and the dental gyrus 
(C and D) of the hippocampus 
of sham (A and C) and ACVS (B 
and D). The expression levels 
of GAD67 (mean ± s.d.) in hip-
pocampal extracts analyzed by 
western blot is reported in graph 
E. The statistical difference vs 
a=3d-Fasted and b=3d-Sham is 
in parenthesis.
Figure 5. A-D The graphs show the expression level of 180 and 140 kDa NCAM (A), the 180/140 kDa ratio (B) and Synaptophysin 
(C) in the hippocampus of rats sacrificed three days after surgery and/or stimulation Representative gels are shown in Fig. 3D. 
The values in the graphs are expressed as mean ± s.d. and the statistical significance is reported in parenthesis: a=3d-Fasted 
and b=3d-Sham.
107
Biomed Rev 30, 2019
Vagus nerve and neurotrophins
500 µs at 30 Hz – 30 sec on / 5 min off) increase the activity 
in the cortical and prefrontal areas (25, 26). A progressive 
involvement of prefrontal and limbic areas is observable when 
treatment is prolonged form one month to one year (chronic). 
In	addition,	Krahl	et	al.	reported	that	the	therapeutic	efficacy	
of VNS in awaked rats is mainly due to the activation of A and 
B-	fibers,	while	higher	stimulatory	parameters	congruent	with	
C-fiber	activation	are	necessary	in	the	anesthetized	animals	
(27), suggesting that the arousal status might be also crucial 
to develop effective vagus based therapies. 
It	 is	 therefore	 likely	 that	 the	 regional	 specific	NGF	and	




of the vagus nerve.
In this context, it is worth to note that the neurotrophin 
changes by ACVS persist for three days after stimulation and 
are associated with the induction of plasticity markers and 
GABA expression in the hippocampus. 
Anatomical, electrophysiological and imaging studies 
have demonstrated that the hippocampus is one of the limbic 
structures that subserve the neurobehavioral effects of vagus 
nerve stimulation (8, 9). Vagal stimulation enhances long-term 
potentiation in the dental gyrus of hippocampus (11) and in-
creases synaptic activity in this brain region, as demonstrated 
by	PET	analysis	(9),	further	confirming	the	modulatory	role	
of the vagus nerve on hippocampal activity. 
The present study shows that within two hours after ACVS, 
the hippocampal expression of the molecular plasticity 
markers 180 kDa NCAM and SYP, and the GABA biosynthetic 
enzyme GAD67 were enhanced (Experiment 1). Three days 
after ACVS, the hippocampal levels of GAD67 and NCAM 
were still increased and these molecular changes were associ-
ated with an increased distribution of GAD67-positive nerves 
in the hippocampus. 
The increased expression of SYP (26, 27) and NCAM (28, 
29) in the hippocampus are markers of synaptic plasticity and 
stabilization following LTP and memory consolidation. The 
cognitive improvement following physical exercise and envi-
ronmental enrichment is also characterized by an up-regulation 
of SYP (30, 31) and NCAM (34) and morphological changes in 
the hippocampus. On the contrary, perturbation of the NCAM 
expression by genetic or pharmacological methods (29, 33) 
affects behavioral performance and hippocampal plasticity, 
indicating a direct role of these molecules in the promotion 
and/or guidance of the morpho-functional rearrangement of 
the hippocampal network. 
Since neurotrophins contribute to synaptic plasticity and 
their synthesis and release in the hippocampus is also activity-
dependent (15), it is likely that neurotrophin changes caused 
by	ACVS	might	reflect	the	action	of	the	vagus	nerve	on	hip-
pocampal neurons. In line with this suggestion, we observe 
that ACVS induces an early up-regulation of hippocampal 
GAD67,	which	results	in	a	later	modification	of	GABA	cell	
distribution in the hippocampus. Since GABA cells in the 
brain are neurotrophin targets (36) and synthetize NGF upon 
stimulation (37), it is likely that ACVS might activate, and/
or potentiate, the brain Neurotrophins/GABA system, which 
may	reflect	on	normal	learning	and	memory	(38)	and	serve	as	
a self-protective in pathological conditions (39).
Neese et colleague (40) suggested that the vagus nerve-
mediated increase in GAD67-positive cells in the hilum of 
hippocampus following injury might result by either increased 
neurogenesis or by an increased commitment of newly born 
neurons into a GABAergic phenotype. In the hippocampus, 
the survival of mature and immature neurons as well as the 
differentiation of neuronal progenitors, including GABA (41), 
are under control of neurotrophins. It is thus likely that VNS-
induced changes on NGF and BDNF synthesis might produce 
double effects stimulating plasticity and trophism of mature 
neurons and neurogenesis. This hypothesis is currently under 
investigation in our laboratory. 
In conclusion, our study showing that ACVS modulates 
neurotrophins synthesis in the brain and results in molecular 
and structural changes in the hippocampus consolidate the 
role of the vagus nerve as a mediator of the peripheral-brain 
network.	 In	 addition,	 our	 findings	 that	 regional	 selective	
changes of NGF and BDNF might be induced by varying the 
stimulatory parameters and conditions offer a new insight 
into the mechanism of vagal stimulation in neurological and 
psychiatric diseases.
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